{"id":1063146,"date":"2011-11-20T16:55:15","date_gmt":"2011-11-20T16:55:15","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/letter-to-the-international-stem-cell-corporation-shareholders-and-followers\/"},"modified":"2024-08-17T20:27:24","modified_gmt":"2024-08-18T00:27:24","slug":"letter-to-the-international-stem-cell-corporation-shareholders-and-followers-2","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/letter-to-the-international-stem-cell-corporation-shareholders-and-followers-2.php","title":{"rendered":"Letter to the International Stem Cell Corporation Shareholders and Followers"},"content":{"rendered":"<div><a href=\"http:\/\/4.bp.blogspot.com\/-60Cp0n2fUUw\/TsMUxhJbKYI\/AAAAAAAADew\/MvNryjC_Zy4\/s1600\/InternationalStemCellCorporationLogo.jpg\"><img loading=\"lazy\" decoding=\"async\" border=\"0\" height=\"46\" src=\"http:\/\/www.longevitymedicine.tv\/wp-content\/plugins\/wp-o-matic\/cache\/f9896_InternationalStemCellCorporationLogo.jpg\" width=\"320\" style=\"padding-left:10px; padding-right: 10px;\"><\/a><\/div><div><span>To the shareholders and followers of International Stem Cell Corporation:<\/span><\/div><div><\/div><div><span>You&rsquo;ve likely seen stem cells in the news recently, and we&rsquo;d like to take an opportunity to give you our views on two of the recent announcements.&nbsp; <\/span><\/div><div><\/div><div><span>First, International Stem Cell Corporation announced yesterday earnings for the third quarter 2011.&nbsp; We&rsquo;ll be hosting a conference call on Thursday, November 17, 2011 at 10:00 AM PST to discuss key developments in the quarter, provide our outlook and answer your questions.&nbsp;&nbsp; Individuals interested in listening to the conference call may do so by dialing 877-407-8033 for domestic callers or 201-689-8033 for international callers, or from the webcast on the investor relations section of the Company&rsquo;s Web site at <a href=\"http:\/\/www.internationalstemcell.com\/\">http:\/\/www.internationalstemcell.com<\/a>.&nbsp; <\/span><\/div><div><\/div><div><span>Second, Geron&rsquo;s decision, announced yesterday, to terminate its stem cell R&amp;D program in no way affects ISCO&rsquo;s current strategy or developmental activities, nor does it alter our optimism for the potential of stem cells to eventually treat a broad-range of diseases and conditions.&nbsp; While Geron may be reprioritizing programs, we are committed to the course we are on.&nbsp; <\/span><\/div><div><\/div><div><span>Additionally, ISCO will continue its discussions with CIRM regarding possible funding for our truly unique parthenogenesis technology, particularly in light of the $25 million previously earmarked for Geron coming available for other investments.<\/span><\/div><div><\/div><div><span>Thank you for your interest in ISCO.&nbsp; We hope you will join us for the conference call.<\/span><\/div><div><span>Sincerely,<\/span><\/div><div><span>Ken Aldrich<\/span><\/div><div><img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"http:\/\/www.longevitymedicine.tv\/wp-content\/plugins\/wp-o-matic\/cache\/fe46c_8227825955511981707-1520142871599640708?l=intlstemcell.blogspot.com\" alt=\"\" style=\"padding-left:10px; padding-right: 10px;\"><\/div><p>Source:<br><a href=\"http:\/\/intlstemcell.blogspot.com\/feeds\/posts\/default?alt=rss\">http:\/\/intlstemcell.blogspot.com\/feeds\/posts\/default?alt=rss<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>To the shareholders and followers of International Stem Cell Corporation:You&rsquo;ve likely seen stem cells in the news recently, and we&rsquo;d like to take an opportunity to give you our views on two of the recent announcements.&nbsp; First, International Stem Cell &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/letter-to-the-international-stem-cell-corporation-shareholders-and-followers-2.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25,1246878],"tags":[],"class_list":["post-1063146","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy","category-stem-cells"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063146"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1063146"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063146\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1063146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1063146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1063146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}